Global Patent Index - EP 1268852 A1

EP 1268852 A1 20030102 - USE OF A MUTATION IN THE GENE FOR THE BETA-3-SUBUNIT OF HUMAN G-PROTEIN

Title (en)

USE OF A MUTATION IN THE GENE FOR THE BETA-3-SUBUNIT OF HUMAN G-PROTEIN

Title (de)

VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE BETA-3-UNTEREINHEIT DES HUMANEN G-PROTEINS

Title (fr)

UTILISATION D'UNE MODIFICATION GENETIQUE DANS LE GENE CODANT POUR LA SOUS-UNITE BETA-3 DE LA PROTEINE G HUMAINE

Publication

EP 1268852 A1 20030102 (DE)

Application

EP 01911592 A 20010205

Priority

  • DE 10004681 A 20000203
  • DE 10007587 A 20000221
  • DE 10030945 A 20000624
  • EP 0101196 W 20010205

Abstract (en)

[origin: WO0157246A1] The invention relates to the use of a mutation in the gene for the beta 3 subunit of human G proteins. Adenine is substituted by thymine at site 1, in position 657, in exon 9 and/or guanine is substituted by adenine at site 1, in position 814, in exon 10 and/or adenine is substituted by guanine at site 1, in position (-350), in the promoter area and/or adenine is substituted by cytosine at site 1, in position 3882, in intron 9 and/or guanine is substituted by adenine at site 1, in position 5177, in intron 9 and/or guanine is substituted by adenine at site 1, in position 5249, in intron 9 and/or there is an insert consisting the nucleotides cytosine-adenine-cytosine-adenine at site 1, in position 6496, in intron 10, for predicting physiological and pathophysiological conditions in the human body.

[origin: WO0157246A1] The invention relates to the use of a mutation in the gene for the beta 3 subunit of human G proteins. Adenine is substituted by thymine at site 1, in position 657, in exon 9 and/or guanine is substituted by adenine at site 1, in position 814, in exon 10 and/or adenine is substituted by guanine at site 1, in position (-350), in the promoter area and/or adenine is substituted by cytosine at site 1, in position 3882, in intron 9 and/or guanine is substituted by adenine at site 1, in position 5177, in intron 9 and/or guanine is substituted by adenine at site 1, in position 5249, in intron 9 and/or there is an insert consisting the nucleotides cytosine-adenine-cytosine-adenine at site 1, in position 6496, in intron 10, for predicting physiological and pathophysiological conditions in the human body.

IPC 1-7

C12Q 1/68

IPC 8 full level

C12Q 1/68 (2006.01)

CPC (source: EP US)

C12Q 1/6883 (2013.01 - EP US); C12Q 2600/156 (2013.01 - EP US)

Citation (search report)

See references of WO 0157246A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0157246 A1 20010809; AU 4058501 A 20010814; CA 2399141 A1 20010809; EP 1268852 A1 20030102; US 2003129616 A1 20030710

DOCDB simple family (application)

EP 0101196 W 20010205; AU 4058501 A 20010205; CA 2399141 A 20010205; EP 01911592 A 20010205; US 20300902 A 20021125